CPT1A and prostate carcinoma: In prostate cancer it has been shown that fatty acid oxidation plays an important role in cancer metabolism and that targeting CPT-1A with known inhibitors such as etomoxir leads to cell apoptosis and a reduction in cell proliferation39.